RE: Amazing17 Jul 2024 10:37
Lemonade / Apox,
When reducing inventory, they were able to sell those goods (c. £2m of goods) without any production costs. If they hadn’t done this, they’d have made a loss over the period.
Whether inventory was already too high is debatable, but the key thing is that they cannot continue to do this, so if things don’t improve for the underlying business, it will make a loss, and it will continue to do so until things improve.
I first invested in CRL in 2021, so I’m all for investing in the company, but there is a lot more risk here now than there was previously.
Those high fixed costs and a weak balance sheet force the company into a situation where increasing revenue is absolutely imperative. If they fail to do this, they will fail to turn a profit, and the company will eventually go bankrupt. Other companies, with more robust balance sheets and/or higher variable costs, have much more resilience, so the market is pricing in this additional risk, and rightly so.
There’s a huge opportunity here to make some serious returns, but revenue has to increase, and quickly, imo.
If you look back at Bernard’s last few presentations, he was expecting a turnaround long before now (by March 2023, from memory). There were no warnings back then of a rapidly declining contract sales business. If Bernard couldn’t foresee where CRL was/is going, I highly doubt that any of us can.
It’s simply too risky for me at the moment. I’d rather wait for the start of the turnaround (and make lower returns, admittedly) than roll the dice. In my opinion, this is too speculative atm to be considered a true investment, and that’s before factoring in that it’s under new management.
Also, something worth considering is that CRL clearly has no pricing power; the company was not, and is not, able to pass on cost inflation to consumers (and that includes B2B).
My dad remains a shareholder here, so I’m often in discussion about CRL with him. He shares my views, but it is happy to roll the dice, whereas I am not, at present.
All in my honest opinion. Do your own research.